Colin Biggin
Vermögen: 7 Mio $ am 30.06.2026
Vermögen: 7 Mio $ am 30.06.2026
Colin Biggin is currently a Member at The Royal Society of Chemistry and the Society of Nuclear Medicine & Molecular Imaging.
Since 2017, Dr. Biggin has been Chief Operating Officer at Clarity Pharmaceuticals Ltd., with the COO title starting in 2026.
Dr. Biggin completed undergraduate and doctorate degrees at the University of Glasgow.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.04.2026 | 4’926’458 ( 1.32% ) | 7 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Geschäftsführer | 11.10.2024 |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Commercial Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen